GSK Gsk Plc

TIDMGSK

RNS Number : 8883Q

GlaxoSmithKline PLC

22 February 2019

Issued: 22 February 2019, London UK - LSE Announcement

GSK response to SFO Statement

In reference to the announcement issued by the Serious Fraud Office ("SFO") today, GlaxoSmithKline plc (LSE/NYSE: GSK) is pleased that the SFO have closed their investigation and concluded that no further action is required.

About GSK

GSK is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. For further information please visit www.gsk.com.

 
 GSK enquiries: 
 UK Media enquiries:   Simon Steel        +44 (0) 20 8047   (London) 
                                           5502 
                       Tim Foley          +44 (0) 20 8047   (London) 
                                           5502 
 Analyst/Investor      Sarah Elton-Farr   +44 (0) 208 047   (London) 
  enquiries:                               5194 
                       Jeff McLaughlin    +1 215 751 7002   (Philadelphia) 
 
 
 Cautionary statements regarding forward-looking statements 
  GSK cautions investors that any forward-looking statements or 
  projections made by GSK, including those made in this announcement, 
  are subject to risks and uncertainties that may cause actual 
  results to differ materially from those projected. Such factors 
  include, but are not limited to, those described under Item 
  3.D Principal risks and uncertainties in the company's Annual 
  Report on Form 20-F for 2017. 
 
 
   Registered in England & Wales: 
   No. 3888792 
 
 Registered Office: 
  980 Great West Road 
  Brentford, Middlesex 
  TW8 9GS 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RSPEAFAAAFKNEFF

(END) Dow Jones Newswires

February 22, 2019 06:21 ET (11:21 GMT)

Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024

Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024